Annual report
4323.TEDINET S100YOCW
Period2025-04-01 → 2026-03-31
Filed2026-07-03
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Amends S100YI5H. Amended by S100YOK2 (2026-07-03).
Key figures · 148
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥32.5bn | 2025-04-01 → 2026-03-31 | Cons. | Net sales |
| Revenue | ¥29.3bn | 2024-04-01 → 2025-03-31 | Cons. | Net sales |
| Revenue | ¥26.2bn | 2023-04-01 → 2024-03-31v | Cons. | Net sales (5-year summary) |
| Revenue | ¥23.5bn | 2022-04-01 → 2023-03-31v | Cons. | Net sales (5-year summary) |
| Revenue | ¥21.4bn | 2021-04-01 → 2022-03-31v | Cons. | Net sales (5-year summary) |
| Operating income | ¥3.9bn | 2025-04-01 → 2026-03-31 | Cons. | Operating income |
| Operating income | ¥3.2bn | 2024-04-01 → 2025-03-31 | Cons. | Operating income |
| Ordinary income | ¥4.0bn | 2025-04-01 → 2026-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥3.3bn | 2024-04-01 → 2025-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥2.9bn | 2023-04-01 → 2024-03-31v | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥2.5bn | 2022-04-01 → 2023-03-31v | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥2.1bn | 2021-04-01 → 2022-03-31v | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥3.7bn | 2025-04-01 → 2026-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥3.3bn | 2024-04-01 → 2025-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥2.6bn | 2025-04-01 → 2026-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥2.4bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥2.1bn | 2023-04-01 → 2024-03-31v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥1.8bn | 2022-04-01 → 2023-03-31v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥1.3bn | 2021-04-01 → 2022-03-31v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥2.6bn | 2025-04-01 → 2026-03-31 | Cons. | Profit loss |
| Net income | ¥2.5bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss |
| Total assets | ¥25.3bn | at 2026-03-31 | Cons. | Assets |
| Total assets | ¥22.9bn | at 2025-03-31 | Cons. | Assets |
| Total assets | ¥20.0bn | at 2024-03-31v | Cons. | Total assets (5-year summary) |
| Total assets | ¥17.4bn | at 2023-03-31v | Cons. | Total assets (5-year summary) |
| Total assets | ¥15.5bn | at 2022-03-31v | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥8.5bn | at 2026-03-31 | Cons. | Liabilities |
| Total liabilities | ¥8.1bn | at 2025-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥16.8bn | at 2026-03-31 | Cons. | Net assets |
| Net assets / equity | ¥14.8bn | at 2025-03-31 | Cons. | Net assets |
| Net assets / equity | ¥12.7bn | at 2024-03-31v | Cons. | Net assets |
| Net assets / equity | ¥10.8bn | at 2023-03-31v | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥9.2bn | at 2022-03-31v | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥9.1bn | at 2026-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥7.1bn | at 2025-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥8.8bn | at 2026-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥6.7bn | at 2025-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥7.5bn | at 2024-03-31v | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥6.8bn | at 2023-03-31v | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥6.5bn | at 2022-03-31v | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥3.0bn | 2025-04-01 → 2026-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.8bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.9bn | 2023-04-01 → 2024-03-31v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥1.1bn | 2022-04-01 → 2023-03-31v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥1.2bn | 2021-04-01 → 2022-03-31v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | ¥53m | 2025-04-01 → 2026-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥2.0bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥761m | 2023-04-01 → 2024-03-31v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥542m | 2022-04-01 → 2023-03-31v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥81m | 2021-04-01 → 2022-03-31v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥1.0bn | 2025-04-01 → 2026-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥599m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥424m | 2023-04-01 → 2024-03-31v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥281m | 2022-04-01 → 2023-03-31v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥487m | 2021-04-01 → 2022-03-31v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥106.07 | 2025-04-01 → 2026-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥99.24 | 2024-04-01 → 2025-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥85.08 | 2023-04-01 → 2024-03-31v | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥72.25 | 2022-04-01 → 2023-03-31v | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥56.16 | 2021-04-01 → 2022-03-31v | Cons. | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥677.71 | at 2026-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥596.97 | at 2025-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥516.08 | at 2024-03-31v | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥439.03 | at 2023-03-31v | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥373.43 | at 2022-03-31v | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 66.2% | at 2026-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 64.4% | at 2025-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 63.2% | at 2024-03-31v | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 61.8% | at 2023-03-31v | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 58.9% | at 2022-03-31v | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 16.6% | 2025-04-01 → 2026-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 17.8% | 2024-04-01 → 2025-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 17.8% | 2023-04-01 → 2024-03-31v | Cons. | Rate of return on equity (5-year summary) |
| ROE | 17.8% | 2022-04-01 → 2023-03-31v | Cons. | Rate of return on equity (5-year summary) |
| ROE | 16.7% | 2021-04-01 → 2022-03-31v | Cons. | Rate of return on equity (5-year summary) |
| Employees | 1,683 | at 2026-03-31 | Cons. | Number of employees |
| Employees | 1,613 | at 2025-03-31 | Cons. | Number of employees |
| Employees | 1,847 | at 2024-03-31v | Cons. | Number of employees |
| Employees | 1,687 | at 2023-03-31v | Cons. | Number of employees |
| Employees | 1,448 | at 2022-03-31v | Cons. | Number of employees |
| Revenue | ¥27.4bn | 2025-04-01 → 2026-03-31 | Standalone | Net sales |
| Revenue | ¥24.2bn | 2024-04-01 → 2025-03-31 | Standalone | Net sales |
| Revenue | ¥20.4bn | 2023-04-01 → 2024-03-31v | Standalone | Net sales (5-year summary) |
| Revenue | ¥18.6bn | 2022-04-01 → 2023-03-31v | Standalone | Net sales (5-year summary) |
| Revenue | ¥17.1bn | 2021-04-01 → 2022-03-31v | Standalone | Net sales (5-year summary) |
| Operating income | ¥3.9bn | 2025-04-01 → 2026-03-31 | Standalone | Operating income |
| Operating income | ¥3.0bn | 2024-04-01 → 2025-03-31 | Standalone | Operating income |
| Ordinary income | ¥4.1bn | 2025-04-01 → 2026-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥3.4bn | 2024-04-01 → 2025-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥2.2bn | 2023-04-01 → 2024-03-31v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥2.1bn | 2022-04-01 → 2023-03-31v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.8bn | 2021-04-01 → 2022-03-31v | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥4.1bn | 2025-04-01 → 2026-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥3.4bn | 2024-04-01 → 2025-03-31 | Standalone | Income before income taxes |
| Net income | ¥3.2bn | 2025-04-01 → 2026-03-31 | Standalone | Profit loss |
| Net income | ¥2.7bn | 2024-04-01 → 2025-03-31 | Standalone | Profit loss |
| Net income | ¥1.6bn | 2023-04-01 → 2024-03-31v | Standalone | Net income loss (5-year summary) |
| Net income | ¥1.6bn | 2022-04-01 → 2023-03-31v | Standalone | Net income loss (5-year summary) |
| Net income | ¥1000m | 2021-04-01 → 2022-03-31v | Standalone | Net income loss (5-year summary) |
| Total assets | ¥23.0bn | at 2026-03-31 | Standalone | Assets |
| Total assets | ¥20.4bn | at 2025-03-31 | Standalone | Assets |
| Total assets | ¥17.3bn | at 2024-03-31v | Standalone | Total assets (5-year summary) |
| Total assets | ¥15.5bn | at 2023-03-31v | Standalone | Total assets (5-year summary) |
| Total assets | ¥14.0bn | at 2022-03-31v | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥7.2bn | at 2026-03-31 | Standalone | Liabilities |
| Total liabilities | ¥6.8bn | at 2025-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥15.9bn | at 2026-03-31 | Standalone | Net assets |
| Net assets / equity | ¥13.7bn | at 2025-03-31 | Standalone | Net assets |
| Net assets / equity | ¥11.4bn | at 2024-03-31v | Standalone | Net assets |
| Net assets / equity | ¥10.2bn | at 2023-03-31v | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥8.8bn | at 2022-03-31v | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥7.0bn | at 2026-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥5.1bn | at 2025-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥128.62 | 2025-04-01 → 2026-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥109.22 | 2024-04-01 → 2025-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥65.82 | 2023-04-01 → 2024-03-31v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥66.47 | 2022-04-01 → 2023-03-31v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥42.19 | 2021-04-01 → 2022-03-31v | Standalone | Basic earnings loss per share (5-year summary) |
| Dividend per share | ¥45 | 2025-04-01 → 2026-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥27 | 2024-04-01 → 2025-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥45 | 2023-04-01 → 2024-03-31v | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥32 | 2022-04-01 → 2023-03-31v | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥40 | 2021-04-01 → 2022-03-31v | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥641.61 | at 2026-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥552.55 | at 2025-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥466.42 | at 2024-03-31v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥415.93 | at 2023-03-31v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥358.96 | at 2022-03-31v | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 68.8% | at 2026-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 66.9% | at 2025-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 65.9% | at 2024-03-31v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 65.8% | at 2023-03-31v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 63.0% | at 2022-03-31v | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 21.5% | 2025-04-01 → 2026-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 21.4% | 2024-04-01 → 2025-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 14.9% | 2023-04-01 → 2024-03-31v | Standalone | Rate of return on equity (5-year summary) |
| ROE | 17.2% | 2022-04-01 → 2023-03-31v | Standalone | Rate of return on equity (5-year summary) |
| ROE | 12.7% | 2021-04-01 → 2022-03-31v | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 24,836,920 | at 2026-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 24,836,920 | at 2025-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 12,418,460 | at 2024-03-31v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 12,418,460 | at 2023-03-31v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 6,209,230 | at 2022-03-31v | Standalone | Total number of issued shares (5-year summary) |
| Employees | 1,202 | at 2026-03-31 | Standalone | Number of employees |
| Employees | 1,151 | at 2025-03-31 | Standalone | Number of employees |
| Employees | 1,009 | at 2024-03-31v | Standalone | Number of employees |
| Employees | 926 | at 2023-03-31v | Standalone | Number of employees |
| Employees | 871 | at 2022-03-31v | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 68
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2025-04-01 → 2026-03-31 | −¥94m |
| Reconciling Itemsreconciling | revenue intersegment | 2025-04-01 → 2026-03-31 | −¥94m |
| Reconciling Itemsreconciling | segment assets | at 2026-03-31 | ¥3.1bn |
| Reconciling Itemsreconciling | segment profit | 2025-04-01 → 2026-03-31 | −¥2.1bn |
| Global Businessreportable segment | capex | 2025-04-01 → 2026-03-31 | ¥25m |
| Global Businessreportable segment | depreciation | 2025-04-01 → 2026-03-31 | ¥85m |
| Global Businessreportable segment | employees | at 2026-03-31 | 299 pure |
| Global Businessreportable segment | revenue | 2025-04-01 → 2026-03-31 | ¥2.3bn |
| Global Businessreportable segment | revenue external | 2025-04-01 → 2026-03-31 | ¥2.3bn |
| Global Businessreportable segment | revenue intersegment | 2025-04-01 → 2026-03-31 | ¥78m |
| Global Businessreportable segment | segment assets | at 2026-03-31 | ¥1.9bn |
| Global Businessreportable segment | segment profit | 2025-04-01 → 2026-03-31 | −¥401m |
| Medical Big Data Businessreportable segment | capex | 2025-04-01 → 2026-03-31 | ¥18m |
| Medical Big Data Businessreportable segment | depreciation | 2025-04-01 → 2026-03-31 | ¥40m |
| Medical Big Data Businessreportable segment | employees | at 2026-03-31 | 175 pure |
| Medical Big Data Businessreportable segment | revenue | 2025-04-01 → 2026-03-31 | ¥3.5bn |
| Medical Big Data Businessreportable segment | revenue external | 2025-04-01 → 2026-03-31 | ¥3.5bn |
| Medical Big Data Businessreportable segment | revenue intersegment | 2025-04-01 → 2026-03-31 | ¥6m |
| Medical Big Data Businessreportable segment | segment assets | at 2026-03-31 | ¥3.3bn |
| Medical Big Data Businessreportable segment | segment profit | 2025-04-01 → 2026-03-31 | ¥887m |
| Package Businessreportable segment | capex | 2025-04-01 → 2026-03-31 | ¥26m |
| Package Businessreportable segment | depreciation | 2025-04-01 → 2026-03-31 | ¥49m |
| Package Businessreportable segment | employees | at 2026-03-31 | 269 pure |
| Package Businessreportable segment | revenue | 2025-04-01 → 2026-03-31 | ¥6.9bn |
| Package Businessreportable segment | revenue external | 2025-04-01 → 2026-03-31 | ¥6.9bn |
| Package Businessreportable segment | segment assets | at 2026-03-31 | ¥6.3bn |
| Package Businessreportable segment | segment profit | 2025-04-01 → 2026-03-31 | ¥2.3bn |
| Total Of Reportable Segments And Otherssegment total | capex | 2025-04-01 → 2026-03-31 | ¥129m |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2025-04-01 → 2026-03-31 | ¥310m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2025-04-01 → 2026-03-31 | ¥32.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2025-04-01 → 2026-03-31 | ¥32.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2025-04-01 → 2026-03-31 | ¥94m |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2026-03-31 | ¥22.2bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2025-04-01 → 2026-03-31 | ¥6.0bn |
| Reconciling Itemsreconciling | revenue | 2024-04-01 → 2025-03-31 | −¥114m |
| Reconciling Itemsreconciling | revenue intersegment | 2024-04-01 → 2025-03-31 | −¥114m |
| Reconciling Itemsreconciling | segment assets | at 2025-03-31 | ¥3.3bn |
| Reconciling Itemsreconciling | segment profit | 2024-04-01 → 2025-03-31 | −¥1.8bn |
| Global Businessreportable segment | capex | 2024-04-01 → 2025-03-31 | ¥93m |
| Global Businessreportable segment | depreciation | 2024-04-01 → 2025-03-31 | ¥76m |
| Global Businessreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥2.8bn |
| Global Businessreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥2.8bn |
| Global Businessreportable segment | revenue intersegment | 2024-04-01 → 2025-03-31 | ¥79m |
| Global Businessreportable segment | segment assets | at 2025-03-31 | ¥2.4bn |
| Global Businessreportable segment | segment profit | 2024-04-01 → 2025-03-31 | −¥62m |
| Medical Big Data Businessreportable segment | capex | 2024-04-01 → 2025-03-31 | ¥49m |
| Medical Big Data Businessreportable segment | depreciation | 2024-04-01 → 2025-03-31 | ¥33m |
| Medical Big Data Businessreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥3.2bn |
| Medical Big Data Businessreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥3.2bn |
| Medical Big Data Businessreportable segment | revenue intersegment | 2024-04-01 → 2025-03-31 | ¥556,000 |
| Medical Big Data Businessreportable segment | segment assets | at 2025-03-31 | ¥2.8bn |
| Medical Big Data Businessreportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥662m |
| Package Businessreportable segment | capex | 2024-04-01 → 2025-03-31 | ¥53m |
| Package Businessreportable segment | depreciation | 2024-04-01 → 2025-03-31 | ¥37m |
| Package Businessreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥5.9bn |
| Package Businessreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥5.9bn |
| Package Businessreportable segment | revenue intersegment | 2024-04-01 → 2025-03-31 | ¥4m |
| Package Businessreportable segment | segment assets | at 2025-03-31 | ¥4.7bn |
| Package Businessreportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥1.6bn |
| Total Of Reportable Segments And Otherssegment total | capex | 2024-04-01 → 2025-03-31 | ¥329m |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2024-04-01 → 2025-03-31 | ¥237m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-04-01 → 2025-03-31 | ¥29.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-04-01 → 2025-03-31 | ¥29.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2024-04-01 → 2025-03-31 | ¥114m |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2025-03-31 | ¥19.6bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-04-01 → 2025-03-31 | ¥5.0bn |
| Medical Big Data Businessreportable segment | employees | at 2026-03-31 | 116 pure |
| Package Businessreportable segment | employees | at 2026-03-31 | 264 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,662
| Item | Context | Value | Unit |
|---|---|---|---|
| Net assets (5-year summary) | Prior2YearInstant | 12712107000 | JPY |
| Net assets (5-year summary) | Prior1YearInstant | 14828680000 | JPY |
| Net assets (5-year summary) | CurrentYearInstant | 16830491000 | JPY |
| Total assets (5-year summary) | Prior4YearInstant | 15539989000 | JPY |
| Total assets (5-year summary) | Prior3YearInstant | 17413797000 | JPY |
| Total assets (5-year summary) | Prior2YearInstant | 20022694000 | JPY |
| Total assets (5-year summary) | Prior1YearInstant | 22909637000 | JPY |
| Total assets (5-year summary) | CurrentYearInstant | 25303471000 | JPY |
| Net assets per share (5-year summary) | Prior4YearInstant | 373.43 | |
| Net assets per share (5-year summary) | Prior3YearInstant | 439.03 | |
| Net assets per share (5-year summary) | Prior2YearInstant | 516.08 | |
| Net assets per share (5-year summary) | Prior1YearInstant | 596.97 | |
| Net assets per share (5-year summary) | CurrentYearInstant | 677.71 | |
| Basic earnings loss per share (5-year summary) | Prior4YearDuration | 56.16 | |
| Basic earnings loss per share (5-year summary) | Prior3YearDuration | 72.25 | |
| Basic earnings loss per share (5-year summary) | Prior2YearDuration | 85.08 | |
| Basic earnings loss per share (5-year summary) | Prior1YearDuration | 99.24 | |
| Basic earnings loss per share (5-year summary) | CurrentYearDuration | 106.07 | |
| Diluted earnings per share (5-year summary) | Prior4YearDuration | － | |
| Diluted earnings per share (5-year summary) | Prior3YearDuration | － | |
| Diluted earnings per share (5-year summary) | Prior2YearDuration | － | |
| Diluted earnings per share (5-year summary) | Prior1YearDuration | － | |
| Diluted earnings per share (5-year summary) | CurrentYearDuration | － | |
| Equity to asset ratio (5-year summary) | Prior4YearInstant | 0.589 | |
| Equity to asset ratio (5-year summary) | Prior3YearInstant | 0.618 | |
| Equity to asset ratio (5-year summary) | Prior2YearInstant | 0.632 | |
| Equity to asset ratio (5-year summary) | Prior1YearInstant | 0.644 | |
| Equity to asset ratio (5-year summary) | CurrentYearInstant | 0.662 | |
| Rate of return on equity (5-year summary) | Prior4YearDuration | 0.167 | |
| Rate of return on equity (5-year summary) | Prior3YearDuration | 0.178 | |
| Rate of return on equity (5-year summary) | Prior2YearDuration | 0.178 | |
| Rate of return on equity (5-year summary) | Prior1YearDuration | 0.178 | |
| Rate of return on equity (5-year summary) | CurrentYearDuration | 0.166 | |
| Price earnings ratio (5-year summary) | Prior4YearDuration | 11.4 | |
| Price earnings ratio (5-year summary) | Prior3YearDuration | 12.5 | |
| Price earnings ratio (5-year summary) | Prior2YearDuration | 21.2 | |
| Price earnings ratio (5-year summary) | Prior1YearDuration | 18.2 | |
| Price earnings ratio (5-year summary) | CurrentYearDuration | 18.6 | |
| Net cash provided by used in operating activities (5-year summary) | Prior4YearDuration | 1162919000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | Prior3YearDuration | 1073916000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | Prior2YearDuration | 1888438000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | Prior1YearDuration | 1757556000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | CurrentYearDuration | 3028283000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior4YearDuration | -80912000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior3YearDuration | -541656000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior2YearDuration | -761475000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior1YearDuration | -1976668000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | CurrentYearDuration | 53034000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior4YearDuration | 486858000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior3YearDuration | -280816000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |